This webinar will provide excipient users (pharmaceutical companies, contract manufacturers, and other interested stakeholders) with practical advice and information necessary in order to conduct an elemental impurity risk assessment and ultimately assure compliance with the requirements of ICH Q3D. Discover how and where to source the necessary data and information from excipient and other suppliers, including the literature, internal test results and databases.
The presenter will also cite examples from his own experience with ICH Q3D, USP, and EP compliance and involvement with industry groups dealing with these issues.